Exchange: SHZ Sector: Healthcare Industry: Drug Manufacturers—Specialty & Generic
0.57% CNY5.26
America/New_York / 30 apr 2024 @ 03:04
FUNDAMENTALS | |
---|---|
MarketCap: | 2 180.95 mill |
EPS: | -0.150 |
P/E: | -35.07 |
Earnings Date: | May 22, 2024 |
SharesOutstanding: | 414.63 mill |
Avg Daily Volume: | 16.49 mill |
RATING 2024-04-30 |
---|
B- |
Neutral |
RATINGS | ||
---|---|---|
Rating CashFlow: | Strong Sell | |
Return On Equity: | Sell | |
Return On Asset: | Sell | |
DE: | Buy | |
P/E: | Strong Sell | |
Price To Book: | Strong Buy |
QUARTER GROWTHS | ||||||
---|---|---|---|---|---|---|
4/22 | 1/23 | 2/23 | 3/23 | 4/23 | 1/24 | |
Revenue | ||||||
Gr.Profit | ||||||
Ebit | ||||||
Asset | ||||||
Debt |
PE RATIO: COMPANY / SECTOR |
---|
0.00x |
Company: PE -35.07 | sector: PE 35.84 |
PE RATIO: COMPANY / INDUSTRY |
---|
-0.77x |
Company: PE -35.07 | industry: PE 45.57 |
DISCOUNTED CASH FLOW VALUE |
---|
CNY-2.10 (-139.93%) CNY-7.36 |
Date: 2024-05-05 |
Expected Trading Range (DAY) |
---|
CNY 4.96 - 5.56 ( +/- 5.72%) |
ATR Model: 14 days |
Indicator Signals | |
---|---|
RSI 21 | |
SMA | |
Trend | |
Trend 2 | |
Trend 3 | |
MACD |
Volume Signals | |
---|---|
Price | CNY5.26 (0.57% ) |
Volume | 9.04 mill |
Avg. Vol. | 16.49 mill |
% of Avg. Vol | 54.82 % |
Signal 1: | |
Signal 2: |
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
Date | Signal | @ | Closed | % |
---|
Hainan Shuangcheng Pharmaceuticals Co., Ltd. researches, develops, manufactures, and markets synthesized peptide drugs and active pharmaceutical ingredients worldwide. It offers somatostatin, thymosin, clindamycin hydrochloride, thymopentin, L-carnitine, uranin hydrobromide, inosine, cyclophosphine adenosine, motidine, scopolamine, and sodium ferulate for injections, as well as vitamin B6. The company was founded in 2000 and is based in Haikou, the People's Republic of China.